Alireza Ramezani Selected Research

Triamcinolone (Aristocort)

1/2016	Successful Management of Diffuse Unilateral Subacute Neuroretinitis with Anthelmintics, and Intravitreal Triamcinolone followed by Laser Photocoagulation.
11/2014	Three intravitreal bevacizumab versus two intravitreal triamcinolone injections in recent onset central retinal vein occlusion.
10/2014	Intravitreal bevacizumab injection alone or combined with triamcinolone versus macular photocoagulation in bilateral diabetic macular edema; application of bivariate generalized linear mixed model with asymmetric random effects in a subgroup of a clinical trial.
4/2013	INTRAVITREAL DICLOFENAC VERSUS INTRAVITREAL TRIAMCINOLONE FOR THE TREATMENT OF UVEITIC CYSTOID MACULAR EDEMA.
4/2013	A pilot study of intravitreal diclofenac versus intravitreal triamcinolone for uveitic cystoid macular edema.
8/2012	Three intravitreal bevacizumab versus two intravitreal triamcinolone injections in recent-onset branch retinal vein occlusion.
2/2012	Two-year results of a randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus laser in diabetic macular edema.
9/2011	Initial macular thickness and response to treatment in diabetic macular edema.
4/2011	Intravitreal triamcinolone for acute branch retinal vein occlusion: a randomized clinical trial.
4/2010	Intravitreal bevacizumab versus triamcinolone acetonide for refractory uveitic cystoid macular edema: a randomized pilot study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alireza Ramezani Research Topics

Disease

26	Macular Edema 01/2022 - 09/2006
9	Retinal Vein Occlusion 06/2020 - 12/2006
8	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2022 - 01/2010
5	Macular Degeneration (Age-Related Maculopathy) 04/2018 - 03/2010
3	Inflammation (Inflammations) 01/2022 - 04/2013
3	Uveitis 07/2019 - 04/2013
3	Choroidal Neovascularization 04/2018 - 01/2011
3	Proliferative Vitreoretinopathy 09/2016 - 11/2008
2	Hemorrhage 01/2019 - 01/2010
2	Intermediate Uveitis (Chronic Cyclitis) 01/2013 - 03/2010
2	Cataract (Cataracts) 04/2012 - 04/2010
2	Retinal Detachment (Retinal Detachments) 10/2010 - 11/2008
1	Retinal Degeneration 07/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2022
1	Diabetes Mellitus 01/2022
1	Eosinophilia 07/2019
1	Eye Diseases (Eye Disease) 07/2019
1	Patent Ductus Arteriosus 01/2019
1	Sepsis (Septicemia) 01/2019
1	Eclampsia 12/2018
1	Pre-Eclampsia (Preeclampsia) 12/2018
1	Vascular Diseases (Vascular Disease) 04/2018
1	Central Serous Chorioretinopathy 04/2018
1	Vitreous Hemorrhage 07/2016
1	Cavernous Hemangioma (Cavernous Angioma) 07/2016
1	Ischemia 04/2016
1	Retinitis 01/2016
1	Pain (Aches) 10/2015
1	Endophthalmitis (Ophthalmia) 04/2014
1	Epiretinal Membrane (Epiretinal Membranes) 04/2013
1	Vision Disorders (Hemeralopia) 04/2012
1	Glaucoma 04/2012
1	Choroid Diseases 04/2012
1	Amblyopia (Lazy Eye) 01/2012
1	Cicatrix (Scar) 01/2011
1	Ocular Toxoplasmosis 01/2011
1	Coloboma (Colobomas) 10/2010
1	Retinal Artery Occlusion 09/2010
1	Angiofibroma 09/2010
1	Neoplasms (Cancer) 09/2010
1	Retinal Telangiectasis 01/2010
1	Strabismus (Squint) 04/2008
1	Cysts 01/2007

Drug/Important Bio-Agent (IBA)

22	Bevacizumab (Avastin)FDA Link 01/2022 - 11/2007
18	Triamcinolone (Aristocort)FDA Link 01/2016 - 09/2006
12	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 09/2016 - 09/2006
10	Retinaldehyde (Retinal)IBA 07/2022 - 04/2012
6	Diclofenac (SR 38)FDA LinkGeneric 04/2017 - 03/2010
5	Therapeutic UsesIBA 07/2022 - 01/2011
3	afliberceptIBA 11/2019 - 03/2017
3	Silicone OilsIBA 06/2017 - 11/2008
2	Prednisolone (Predate)FDA LinkGeneric 01/2013 - 01/2011
2	Mydriatics (Cycloplegics)IBA 01/2012 - 04/2008
1	sodium iodateIBA 07/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Ophthalmic Solutions (Eye Drops)IBA 10/2021
1	Lubricant Eye Drops (Artificial Tears)IBA 10/2021
1	KetorolacIBA 10/2021
1	Erythropoietin FDA Link 11/2019
1	Immunoglobulin G (IgG)IBA 07/2019
1	AntibodiesIBA 07/2019
1	Thomsen-Friedenreich antibodiesIBA 07/2019
1	Surface-Active Agents (Surfactants)IBA 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2018
1	Complement Factor H (Factor H)IBA 10/2017
1	C-Reactive ProteinIBA 10/2017
1	Analgesics (Analgesic Drugs)IBA 04/2017
1	Oxygen (Dioxygen)IBA 04/2016
1	Enalapril FDA LinkGeneric 04/2016
1	AnthelminticsIBA 01/2016
1	Celecoxib (Celebrex)FDA Link 10/2015
1	Meloxicam (Mobic)FDA LinkGeneric 10/2015
1	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2015
1	Immunomodulating AgentsIBA 06/2015
1	Colchicine FDA LinkGeneric 03/2015
1	Imatinib Mesylate (Gleevec)FDA Link 01/2015
1	Betamethasone (Celestone)FDA Link 01/2013
1	Pyrimethamine (Daraprim)FDA Link 01/2011
1	Methotrexate (Mexate)FDA LinkGeneric 01/2011
1	Sulfadiazine (Sulphadiazine)FDA Link 01/2011
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2011
1	Clindamycin (Cleocin)FDA LinkGeneric 01/2011
1	Polyvinyl AlcoholIBA 09/2010
1	Pharmaceutical PreparationsIBA 03/2010
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2010
1	SiliconesIBA 11/2008

Therapy/Procedure

12	Light Coagulation 01/2022 - 11/2007
10	Intravitreal Injections 10/2021 - 04/2008
8	Injections 01/2022 - 09/2006
8	Lasers (Laser) 04/2017 - 11/2007
6	Vitrectomy 06/2017 - 11/2008
3	Therapeutics 07/2022 - 04/2016
1	Laser Therapy (Surgery, Laser) 01/2022
1	Blood Transfusion (Blood Transfusions) 01/2019
1	Scleral Buckling 09/2016
1	Analgesia 10/2015
1	Cataract Extraction 04/2013
1	Operative Surgical Procedures 10/2010
1	Cryotherapy (Therapy, Cold) 01/2010
1	Vitreoretinal Surgery 11/2008